תאריך: 30/03/2015
Sickle cell disease (SCD) affects 12 000–15 000 individuals in the UK. Whilst homozygous SCD (sickle cell anaemia — HbSS) is the most common and severe genotype, and is where most of the evidence exists, this guidance should be used for all genotypes of SCD
British Journal of Haematology, 2015, 169, 492–505 doi: 10.1111/bjh.13348